0
13

In This Issue
  |  
The American Journal of Psychiatry

August 01, 2005, Vol. 162, No. 8
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue
In This Issue
Editorial
What Do We Know About Drug Addiction?
Nora D. Volkow, M.D.
Reviews and Overviews
The Neural Basis of Addiction: A Pathology of Motivation and Choice
Peter W. Kalivas, Ph.D.; Nora D. Volkow, M.D.
Addiction: A Disease of Learning and Memory
Steven E. Hyman, M.D.
Anticraving Medications for Relapse Prevention: A Possible New Class of Psychoactive Medications
Charles P. O’Brien, M.D., Ph.D.
Medication Development for Addictive Disorders: The State of the Science
Frank J. Vocci, Ph.D.; Jane Acri, Ph.D.; Ahmed Elkashef, M.D.
Pharmacotherapy and Pharmacogenetics of Nicotine Dependence
Wade H. Berrettini, M.D., Ph.D.; Caryn E. Lerman, Ph.D.
Behavioral Therapies for Drug Abuse
Kathleen M. Carroll, Ph.D.; Lisa S. Onken, Ph.D.
Effects of Methamphetamine Dependence and HIV Infection on Cerebral Morphology
Terry L. Jernigan, Ph.D.; Anthony C. Gamst, Ph.D.; Sarah L. Archibald, M.A.; Christine Fennema-Notestine, Ph.D.; Monica Rivera Mindt, Ph.D.; Thomas L. Marcotte, Ph.D.; Robert K. Heaton, Ph.D.; Ronald J. Ellis, M.D.; Igor Grant, M.D.
PET Imaging of Dopamine D2 Receptors in Monkey Models of Cocaine Abuse: Genetic Predisposition Versus Environmental Modulation
Michael A. Nader, Ph.D.; Paul W. Czoty, Ph.D.
Co-Occurring Mental and Substance Use Disorders: The Neurobiological Effects of Chronic Stress
Kathleen T. Brady, M.D., Ph.D.; Rajita Sinha, Ph.D.
Developments in the Epidemiology of Drug Use and Drug Use Disorders
Wilson M. Compton, M.D., M.P.E.; Yonette F. Thomas, Ph.D.; Kevin P. Conway, Ph.D.; James D. Colliver, Ph.D.
Article
Postdischarge Cannabis Use and Its Relationship to Cocaine, Alcohol, and Heroin Use: A Prospective Study
Efrat Aharonovich, Ph.D.; Xinhua Liu, Ph.D.; Sharon Samet, M.S.W.; Edward Nunes, M.D.; Rachel Waxman, B.A.; Deborah Hasin, Ph.D.
Correlation of Alcohol Craving With Striatal Dopamine Synthesis Capacity and D2/3 Receptor Availability: A Combined [18F]DOPA and [18F]DMFP PET Study in Detoxified Alcoholic Patients
Andreas Heinz, M.D.; Thomas Siessmeier, M.D.; Jana Wrase, Dipl.-Psych.; Hans Georg Buchholz, Ph.D.; Gerhard Gründer, M.D.; Yoshitaka Kumakura, M.D., Ph.D.; Paul Cumming, Ph.D.; Mathias Schreckenberger, M.D.; Michael N. Smolka, M.D.; Frank Rösch, Ph.D.; Karl Mann, M.D.; Peter Bartenstein, M.D.
Screening for Alcohol Use Disorders Among Medical Outpatients: The Influence of Individual and Facility Characteristics
Mayur M. Desai, Ph.D., M.P.H.; Robert A. Rosenheck, M.D.; Thomas J. Craig, M.D., M.P.H.
Brief Report
Hippocampus Volume and Treatment Delays in First-Episode Schizophrenia
Beng-Choon Ho, M.R.C.Psych.; Daniel Alicata, M.D.; Carmencita Mola, M.D.; Nancy C. Andreasen, M.D., Ph.D.
MRI Analysis of Cerebellar Vermal Abnormalities in Bipolar Disorder
Neil P. Mills, B.S.; Melissa P. DelBello, M.D.; Caleb M. Adler, M.D.; Stephen M. Strakowski, M.D.
Modulation of Attention During Visual Masking in Schizophrenia
Yuri Rassovsky, Ph.D.; Michael F. Green, Ph.D.; Keith H. Nuechterlein, Ph.D.; Bruno Breitmeyer, Ph.D.; Jim Mintz, Ph.D.
Six-Month, Blinded, Multicenter Continuation Study of Ziprasidone Versus Olanzapine in Schizophrenia
George M. Simpson, M.D.; Peter Weiden, M.D.; Theresa Pigott, M.D.; Stephen Murray, M.D., Ph.D.; Cynthia O. Siu, Ph.D.; Steven J. Romano, M.D.
Reduced Left Angular Gyrus Volume in First-Episode Schizophrenia
Jay Nierenberg, M.D., Ph.D.; Dean F. Salisbury, Ph.D.; James J. Levitt, M.D.; Elizabeth A. David, B.A.; Robert W. McCarley, M.D.; Martha E. Shenton, Ph.D.
Letter to the Editor
Reversal of Symptomatic Hyperprolactinemia by Aripiprazole
REBECCA WAHL, M.D.; ROBERT OSTROFF, M.D.
Topiramate-Induced Psychosis
DANA KOBER, M.D.; GLEN O. GABBARD, M.D.
Clozapine-Induced Allergic Vasculitis
KENAN M. PENASKOVIC, M.D.; SIDDHARTHA ANNAMRAJU, M.D.; JOHN E. KRAUS, M.D., Ph.D.
Smokeless Tobacco for a Nicotine-Dependent Schizoaffective Patient
RAYMOND BUNCH, M.D.; MARSHALL THOMAS, M.D.; NORMAN BUNCH, D.D.S., M.S.
Comfort, Self-Confidence, Safety, and Dopamine D2 Receptor Occupancy by Antipsychotics
LIEUWE de HAAN, M.D., Ph.D.; JULES LAVALAYE, M.D., Ph.D.; JAN BOOIJ, M.D., Ph.D.; DON LINSZEN, M.D., Ph.D.
Antidepressants for Bipolar Depression
S. NASSIR GHAEMI, M.D., M.P.H.; FREDERICK K. GOODWIN, M.D.
Schneiderian First-Rank Symptoms and Right Parietal Hyperactivation: A Replication Using fMRI
VENKATASUBRAMANIAN GANESAN, M.B.B.S., M.D.; MIKE D. HUNTER, M.B.Ch.B., M.R.C.Psych.; SEAN A. SPENCE, M.D., M.B.B.S., B.Sc., M.R.C.Psych.
Antidepressants for Bipolar Depression
ROBERT M.A. HIRSCHFELD, M.D.; LAURA J. FOCHTMANN, M.D.; JOHN S. MCINTYRE, M.D.
Antidepressants for Bipolar Depression
JEFFREY C. FETTER, M.D.; KATHLEEN D. ASKLAND, M.D.
Dr. Gijsman and Colleagues Reply
HARM J. GIJSMAN, Ph.D., M.R.C.Psych.; JOHN R. GEDDES, M.D., F.R.C.Psych.; JENNIFER M. RENDELL, M.Sc.; GUY M. GOODWIN, D.Phil. F.R.C.Psych.; WILLEM A. NOLEN, Ph.D.
Extended-Release Divalproex Sodium for Patients With Side Effects From Delayed-Release Divalproex Sodium
LANCE P. LONGO, M.D.
Defining the Core Processes of Psychotherapy
BERNARD D. BEITMAN, M.D.
Defining the Core Processes of Psychotherapy
JITENDER SAREEN, M.D., F.R.C.P.C.; KURT SKAKUM, M.D., F.R.C.P.C.
A Simplistic Understanding of the Five-Factor Model
THOMAS A. WIDIGER, Ph.D.; TIMOTHY J. TRULL, Ph.D.
Dr. Cutler and Colleagues Reply
JANIS L. CUTLER, M.D.; ADAM GOLDYNE, M.D.; JOHN C. MARKOWITZ, M.D.; MICHAEL J. DEVLIN, M.D.; ROBERT A. GLICK, M.D.
Drs. Shedler and Westen Reply
JONATHAN SHEDLER, Ph.D.; DREW WESTEN, Ph.D.
The “Infallibility” of Psychopathology
DONALD MENDER, M.D.
Dr. Alexopoulos Replies
GEORGE S. ALEXOPOULOS, M.D.
Book Forum: Childhood Resilience
Hidden From the Holocaust: Stories of Resilient Children Who Survived and Thrived
RACHEL G. KLEIN, Ph.D.
Resilience and Vulnerability: Adaptation in the Context of Childhood Adversities
ANDRÉS MARTIN, M.D., M.P.H.; WANJIKU NJOROGE, M.D.
Book Forum: Geriatric Psychiatry
Dementia: Presentations, Differential Diagnosis, and Nosology, 2nd ed.
FRANCES R. FRANKENBURG, M.D.
Comprehensive Textbook of Geriatric Psychiatry, 3rd ed.
PETER V. RABINS, M.D., M.P.H.
Book Forum: Substance Abuse
A Handbook on Drug and Alcohol Abuse: The Biomedical Aspects, 4th ed.
TIMOTHY W. FONG, M.D.
Marijuana and Madness
SHEILA B. BLUME, M.D.
Neurological Aspects of Substance Abuse, 2nd ed.
SADIQ Al-SAMARRAI, M.D.; SANJAY GUPTA, M.D.
Treating Alcohol and Drug Abuse: An Evidence Based Review
WILLIAM R. FLYNN, M.D.
Book Forum: Personality and Personality Disorders
Paradigms of Personality Assessment
THOMAS A. WIDIGER, Ph.D.
Practical Management of Personality Disorder
PAUL S. LINKS, M.D., M.Sc., F.R.C.P.C.
Images In Neuroscience
Cell Death
Michael W. Vogel, Ph.D.
Images in Psychiatry
Vladimir Bekhterev, 1857–1927
Vladimir Lerner, M.D., Ph.D.; Eliezer Witztum, M.D.
Introspections
Group Therapy in a Combat Zone?
Paul Croarkin, D.O.
Correction
Correction
APA Official Actions
2004 Annual Report of the American Board of Psychiatry and Neurology, Inc.
American Board of Psychiatry and Neurology, Inc. Report on the 2004 Examinations
  |  
Copyright ©
American
Psychiatric
Association